The Europe respiratory care devices market is expected to grow from US$ 5,587.97 million in 2022 to US$ 9,179.17 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2022 to 2028.
Chronic respiratory diseases (CRDs) affect the airways and other structures of the lungs. Chronic obstructive pulmonary diseases (COPD), asthma, occupational lung diseases, and pulmonary hypertension are among the most common CRDs. Among all CRDs, Asthma is one of the most common and popular noncommunicable diseases, which is observed in all ages. The prevalence of asthma is increasing at an alarming rate due to the rising incidence of allergic reactions toward pollen, dust, and other allergens and increasing environmental pollution. A few main symptoms of asthma are cough, wheeze, breath shortness, and chest tightness. The UK have exceptionally high asthma rates among all the regions. According to an article published in British Medical Journal (BMJ), in the UK, asthma-associated deaths increased by 33% between 2008 and 2018. Age-related asthma disparity is presented as the number of deaths due to asthma; it holds a significant value in 55-64 years of patients. Further, COPD encompasses a group of lung diseases caused by persistent airflow limitation, exhalation prolongation, and lung elasticity loss. It is a progressive and debilitating disease associated with an increased inflammatory response in the airways. According to an article published in The Lancet in May 2022, the global prevalence of COPD was 10.3% in 2019, accounting for 391.9 million cases among people aged 30–79 years. According to WHO, COPD is the third leading cause of death across the world, causing 3.23 million deaths in 2019. As per the American Society of Health-System Pharmacists (ASHP), currently, there are four types of devices to deliver various COPD medications—pressurized metered-dose inhalers (pMDI), dry powder inhalers (DPI), soft mist inhalers (SMI), and nebulizers. Various drug-delivery protocols, including parenteral and oral drug delivery, are developed to treat asthma and COPD. However, the most effective treatment option is the pulmonary drug delivery system, compared to the other conventional methods. Respiratory care devices are highly used in the treatment of asthma and COPD. Thus, the rising prevalence and cases of these diseases and the surging demand for respiratory care devices are expected to boost the market growth in the coming years. Asthma and COPD symptoms and causes are equivalent to the signs of COVID-19. According to the paper published by the Journal of Allergy and Clinical Immunology, in 2020, patients with COPD and asthma increased adherence to inhalers medications during the COVID-19 pandemic. As a result, a few countries in the region, such as the UK, experienced a shortage of inhalers because of their high use during the COVID-19 pandemic. Thus, the pandemic has created lucrative opportunities for the respiratory care devices manufacturers.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the respiratory care devices market growth at a notable CAGR during the forecast period.
Europe Respiratory Care Devices Market Revenue and Forecast to 2028 (US$ Million)
Europe Respiratory Care Devices Market Segmentation
The market for Europe respiratory care devices market is segmented into product, indication, end user and country. Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. The market for the therapeutics devices segment is sub segmented into positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, and others. The market for the monitoring device segment is sub segmented into pulse oximeters, scenography, and gas analyzers. The market for the diagnostic devices segment is further segmented into spirometers, polysomnography devices, peak flow meters, and other diagnostic devices. The market for the consumables & accessories segment is sub segmented into masks, disposable resuscitators, tracheostomy tubes, breathing circuits, and other consumables and accessories. By indication, the market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Based on end user, the Europe respiratory care devices market is divided into hospitals, home care, and ambulatory care. Based on country, the Europe respiratory care devices market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe.
Europe Respiratory Care Devices Market—Companies Mentioned
Koninklijke Philips N.V.; ResMed Inc.; Medtronic; Masimo; THERMO FISHER SCIENTIFIC INC; Dragerwerk AG & Co. KGaA; Invacare Corporation; Getinge AB.; Nihon Kohden Corporation; Air Liquide; and Teleflex Incorporated are a few major companies operating in the Europe respiratory care devices market.